2019-03-28
Proteo’s Elafin Enters The Clinic For Subcutaneous Use In Pulmonary Arterial Hypertension
Proteo focuses on the development of therapeutic solutions based on the body's own protective tools and weapons for diseases with significant unmet needs.
The company develops Elafin for the prevention of life-threatening complications in highly invasive major surgery and the treatment of life-threatening diseases like pulmonary arterial hypertension.
2019-03-28
Proteo’s Elafin Enters The Clinic For Subcutaneous Use In Pulmonary Arterial Hypertension
